762 related articles for article (PubMed ID: 23842045)
1. The reliability of HBV core antibody in serological screening for hepatitis B virus.
Ba Alawi F; Robertson PW; LePage AK; Jayamaha J; Baleriola C; Rawlinson WD
Pathology; 2013 Aug; 45(5):501-5. PubMed ID: 23842045
[TBL] [Abstract][Full Text] [Related]
2. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
3. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
4. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
Kuhns MC; Busch MP
Mol Diagn Ther; 2006; 10(2):77-91. PubMed ID: 16669606
[TBL] [Abstract][Full Text] [Related]
5. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus markers in anti-HBc only positive individuals.
Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
[TBL] [Abstract][Full Text] [Related]
7. A single-center, single-blind study to evaluate the clinical sensitivity, specificity, and agreement between Elecsys Anti-HBc II and Elecsys Anti-HBc in a Korean population.
Lee T; Yang JJ; Eom J; Kwon S; Park BG; Hwang SH; Oh HB
J Clin Virol; 2018 Dec; 109():41-44. PubMed ID: 30419551
[TBL] [Abstract][Full Text] [Related]
8. Donor screening for hepatitis B virus infection in a cell and tissue bank.
Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
[TBL] [Abstract][Full Text] [Related]
9. Occult hepatitis B virus infection.
Allain JP
Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
[TBL] [Abstract][Full Text] [Related]
10. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
11. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
Sanders RC; Lewis D; Dyke T; Alpers MP
P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
[TBL] [Abstract][Full Text] [Related]
12. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany.
Houareau C; Offergeld R
Vox Sang; 2019 Jul; 114(5):459-466. PubMed ID: 30968958
[TBL] [Abstract][Full Text] [Related]
13. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
Kiely P; Margaritis AR; Seed CR; Yang H;
Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers.
Alzahrani FM; Muzaheed ; Shaikh SS; Alomar AI; Acharya S; Elhadi N
Ann Lab Med; 2019 Jan; 39(1):81-85. PubMed ID: 30215234
[TBL] [Abstract][Full Text] [Related]
16. Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks.
Bamaga MS; Azahar EI; Al-Ghamdi AK; Alenzi FQ; Farahat FM
Saudi Med J; 2009 Nov; 30(11):1416-21. PubMed ID: 19882053
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
[TBL] [Abstract][Full Text] [Related]
18. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
[TBL] [Abstract][Full Text] [Related]
19. Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.
Yuan Q; Song LW; Cavallone D; Moriconi F; Cherubini B; Colombatto P; Oliveri F; Coco BA; Ricco G; Bonino F; Shih JW; Xia NS; Brunetto MR
PLoS One; 2015; 10(6):e0130209. PubMed ID: 26115521
[TBL] [Abstract][Full Text] [Related]
20. Occult hepatitis B virus infection: implications in transfusion.
Allain JP
Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
